Cargando…

Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan

Background: Among several factors that impair adherence to available therapies in type 2 diabetes mellitus (T2DM) is the complexity of the dosing regimen. Moreover, the value of a once-weekly (QW) administration of oral medications for T2DM compared to once, twice, or thrice daily (QD, BID, TID) reg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sen, Rohini, Shields, Alan L., Atsuda, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2016
Materias:	Endocrine Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471358/ https://www.ncbi.nlm.nih.gov/pubmed/37663012 http://dx.doi.org/10.36469/9826

Ejemplares similares

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
por: Satman, Ilhan, et al.
Publicado: (2013)

A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes
por: Cziraky, Mark J., et al.
Publicado: (2019)

Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
por: Wahlqvist, Peter, et al.
Publicado: (2018)

How Do Diabetes Models Measure Up? A Review of Diabetes Economic Models and ADA Guidelines
por: Govan, Lindsay, et al.
Publicado: (2015)

Cost Savings and Reduced Health Care Utilization Associated with Participation in a Digital Diabetes Prevention Program in an Adult Workforce Population
por: Sweet, Cynthia Castro, et al.
Publicado: (2020)

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
por: Mathieu, Chantal, et al.
Publicado: (2013)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
por: Schneider, John E., et al.
Publicado: (2018)

SAT642 Effective Gh Replacement With Once-weekly Somapacitan In Children With Gh Deficiency: 2-year Results From Real4
por: Miller, Bradley Scott, et al.
Publicado: (2023)

Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
por: Vaag, Allan, et al.
Publicado: (2012)

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020)

PSUN223 The Three Different Clinical Phenotypes of Checkpoint Inhibitor-Induced Diabetes Mellitus
por: Perlman, Jordan, et al.
Publicado: (2022)

Occult pyogenic liver abscess in an adolescent with type 2 diabetes
por: Williams, Regina, et al.
Publicado: (2013)

Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
por: Currie, Craig J., et al.
Publicado: (2013)

Hypothyroidism in utero stimulates pancreatic beta cell proliferation and hyperinsulinaemia in the ovine fetus during late gestation
por: Harris, Shelley E., et al.
Publicado: (2017)

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus
por: Onishi, Yukiko, et al.
Publicado: (2012)

Tildacerfont for the Treatment of Patients With Classic Congenital Adrenal Hyperplasia: Results From a 12-Week Phase 2 Clinical Trial in Adults With Classic CAH
por: Auchus, Richard Joseph, et al.
Publicado: (2021)

Patients' preferences for once‐daily oral versus once‐weekly injectable diabetes medications: The REVISE study
por: Boye, Kristina, et al.
Publicado: (2020)

ODP263 A Nonbiased Single-Cell Transcriptomic Analysis of Mouse Mammary Gland after Low Dose/Long Term vs. High Dose/Short Term Exposure to PBDEs
por: Saeki, Kohei, et al.
Publicado: (2022)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Seewoodhary, Jason, et al.
Publicado: (2010)

OR23-4 Low-Dose Gestational BPA Exposure Alters Circadian Rhythms in Mice
por: Nesan, Dinu, et al.
Publicado: (2019)

ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design
por: Fulcher, Gregory R., et al.
Publicado: (2021)

A Randomized Trial of Vitamin D(3) Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption
por: Lewis, R. D., et al.
Publicado: (2013)

RF22 | PMON04 Sex- and Dose-Dependent Effects of In Utero Endocrine Disruptor Exposure on Offspring Behavior and Brain Monoamines
por: MohanKumar, Sheba, et al.
Publicado: (2022)

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
por: Johansen, Pierre, et al.
Publicado: (2019)

MON-036 Lead Exposure Is Related to Macro- and Microvascular Diabetic Complications
por: Wang, Ningjian, et al.
Publicado: (2019)

Challenges and Opportunities for Diabetes Care in the Philippines in the Time of the COVID-19 Pandemic
por: Elvira Arcellana, Anna, et al.
Publicado: (2020)

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase‐4 inhibitors in treatment‐naïve patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2019)

Once-Weekly Exenatide in Youth With Type 2 Diabetes
por: Tamborlane, William V., et al.
Publicado: (2022)

A New Medical Therapy for Multiple Endocrine Neoplasia Type 1?
por: Boharoon, Hessa, et al.
Publicado: (2022)

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults
por: Yuen, Kevin C. J., et al.
Publicado: (2013)

Estrogen Activity of OTC Topical Medications Containing Parabens Depends on Paraben Type and Concentration
por: Allen, Brianna, et al.
Publicado: (2021)

Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study
por: Horii, Takeshi, et al.
Publicado: (2019)

RF27 | LBSUN361 Understanding The Genetics Of Multiple Endocrine Neoplasia Type 1: The Road Ahead
por: Worthy, Charlita
Publicado: (2022)

ODP264 An Unusual Etiology of Hypothyroidism and New-Onset Insulin-Dependent Diabetes: A Rare Side Effect of Opdivo
por: Alchalabi, Halah, et al.
Publicado: (2022)

The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States
por: Wang, Bruce, et al.
Publicado: (2015)

PMON01 Alpelisib (PI3-K Inhibitor) Induced Severe Insulin Resistance Complicated by Diabetic Ketoacidosis (DKA) with Rapid Reversal Following Discontinuation: A Case Report
por: Lloyd, Jacob, et al.
Publicado: (2022)

Does Atrazine Influence Larval Development and Sexual Differentiation in Xenopus laevis?
por: Kloas, Werner, et al.
Publicado: (2009)

Molecular adaptations of adipose tissue to 6 weeks of morning fasting vs. daily breakfast consumption in lean and obese adults
por: Gonzalez, Javier T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s8g3vet4t0la33gb566r79464g